According to the American Cancer Society, by 2023, there will be around 609,360 deaths due to cancer. Of course, there are several things people can do to help eliminate causes of cancer, such as ...

Multicancer blood tests have for years been hyped as a potential breakthrough in early cancer detection. But with news that one of the big names in the field, the Galleri test, failed to meet its ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial results for the first quarter of 2026.

Many cancers do not exhibit symptoms and patients are unaware they have the disease until it has reached an advanced stage — but the Galleri test can change that. Galleri, which can detect cancer in ...

Collaboration With Epic Will Allow Clinicians to Seamlessly Order the Galleri Multi-Cancer Early Detection Test at the Point of Care MENLO PARK, Calif., April 7, 2026 /PRNewswire/ -- GRAIL, Inc.

KENT COUNTY, Mich — A cancer diagnosis can be devastating- the earlier it's found the better. So, what if you could take a blood test to screen for over 50 cancers? The new Galleri multi-cancer early ...

A blood test for more than 50 types of cancer could significantly boost early detection and speed up diagnosis, according to a new study. Made by U.S. pharmaceutical company Grail, the Galleri test ...

The Galleri test will be available to all members, across all plan types, who are over the age of 50 and to all other members with risk factors for developing cancer. 1 The Galleri test is part of the ...

Good afternoon, everyone, and thank you for joining us to review first quarter results. This quarter, we saw continued strong commercial momentum with expanding physician adoption, increasing ...